Abstract 193: Clinico-radiologic Severity of Subarachnoid Hemorrhage Predicts Coated-platelet Levels and Associated In-hospital Morbidity

    loading  Checking for direct PDF access through Ovid


Introduction: Coated-platelets (CP), a subpopulation of activated platelets, can be used as a surrogate marker for systemic thrombogenic propensity. Microthrombosis causes delayed cerebral ischemia (DCI) and is a major determinant of morbidity after subarachnoid hemorrhage (SAH). Association studies have reported increased morbidity and mortality after SAH depending on disease severity at admission.

Hypothesis: We hypothesized that severe clinical and radiological grades of SAH would be associated with increased CP and contribute to DCI.

Methods: Prospective cohort of 44 patients with non-traumatic, spontaneous SAH was enrolled. Clinical and radiological severity was recorded using Hunt and Hess (H&H), World Federation of Neurosurgeons Scale (WFNS), Simplified Applied Physiology Score (SAPS-II), Acute Physiology and Chronic Health Evaluation (APACHE-II) and modified Fisher scale (mFS). DCI and clinical vasospasm were used to assess in-hospital morbidity. CP levels were measured on predetermined days after SAH for each patient using flow cytometry. Mixed linear models were used to study test hypothesis.

Results: Cohort average age was 51.4 (IQR 44-58.5) and women representing 70.5% patients. Fifteen (34.1%) developed symptomatic vasospasm, and imaging identified 21 (47.7%) with DCI. During the first 5 days after SAH, scales indicating severe disease were associated with a 5-10% increase in CP. But this was only significant for mFS, 10.4% higher CP in grades 3 and 4 (95%CI: 1.5%, 19.4%; p=0.0251) than in those with grades 1 and 2. Similarly, higher clinical and radiological severity were associated with subsequent downtrending levels of CP after an initial rise but was only statistically significant for SAPS-II (upper tertile 0.8%/day vs middle tertile 1.7% vs lower tertile 1.02%/day, p=0.0297).

Conclusion: Higher initial CP levels among patients with severe clinico-radiologic findings, along with declining CP trends over 21 days, suggest that neurohumoral triggers may induce systemic thrombogenicity and contribute to DCI and clinical vasospasm after SAH.

Related Topics

    loading  Loading Related Articles